These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4187537)

  • 1. Therapy with progestational agents in advanced benign prostatic hypertrophy.
    Geller J; Angrist A; Nakao K; Newman H
    JAMA; 1969 Nov; 210(8):1421-7. PubMed ID: 4187537
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of progestational agents on gonadal and adrenal cortical function in patients with benign prostatic hypertrophy and carcinoma of the prostate.
    Geller J; Fruchtman B; Meyer C; Newman H
    J Clin Endocrinol Metab; 1967 Apr; 27(4):556-60. PubMed ID: 4164338
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of the long-term effect of anti-androgen therapy by sonometrics in patients with benign prostatic hypertrophy].
    Kimura A; Higuchi T
    Nihon Hinyokika Gakkai Zasshi; 1988 Oct; 79(10):1697-702. PubMed ID: 2471862
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical effects of chlormadinone acetate (Prostal) on patients with prostatic hypertrophy--with reference to estimation of size and weight of prostate by means of transrectal ultrasonotomography].
    Yoshida H; Haraguchi C; Ogawa Y; Kawai N; Ohyama M; Higaki Y; Saitoh T; Imamura K
    Hinyokika Kiyo; 1983 Nov; 29(11):1419-26. PubMed ID: 6203377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical studies on morphological changes in the prostate in patients with benign prostatic hypertrophy after antiandrogen therapy--by means of transrectal ultrasonotomography].
    Suzuki K; Ichinose Y; Hashimoto K; Matsumoto K; Suzuki T; Imai K; Yamanaka H
    Hinyokika Kiyo; 1990 May; 36(5):557-60. PubMed ID: 1698012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gestagens: a new method of hormonal therapy in benign prostatic hypertrophy].
    Vernet D
    Urol Int; 1970; 25(3):263-8. PubMed ID: 4112432
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of histological compositions and apoptosis in canine spontaneous benign prostatic hyperplasia treated with androgen suppressive agents chlormadinone acetate and finasteride.
    Shibata Y; Fukabori Y; Ito K; Suzuki K; Yamanaka H
    J Urol; 2001 Jan; 165(1):289-93. PubMed ID: 11125427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical evaluation of chlormadinone acetate (CMA) in benign prostatic hypertrophy (author's transl)].
    Fujisawa S; Fujii M; Yasui H; Koshito K; Kamiryo Y
    Horumon To Rinsho; 1981 Nov; 29(11):1389-94. PubMed ID: 6176374
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical evaluation of the long-term treatment with chlormadinone acetate in patients with benign prostatic hypertrophy].
    Kogawa T; Yanagiya H; Takashima T; Higashino I; Kudo T; Suzuki T; Mikuni T; Kido K; Tsukui A; Yagihashi Y
    Hinyokika Kiyo; 1993 Mar; 39(3):281-7. PubMed ID: 7685143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies of mechanisms of the action of androgens on prostate. 3. Anti-androgenic effect of gestagenic compounds and treatment of benign prostatic hypertrophy with chlormadinone acetate].
    Shida K; Shimazaki J; Urano E; Kurihara H; Takahashi H
    Nihon Hinyokika Gakkai Zasshi; 1972 Feb; 63(2):109-28. PubMed ID: 4113183
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical results and problems of anti-androgen therapy of benign prostatic hypertrophy].
    Umeda K
    Hinyokika Kiyo; 1991 Nov; 37(11):1429-33. PubMed ID: 1722628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical treatment of benign nodular prostatic hyperplasia with cyproterone acetate.
    Scott WW; Wade JC
    J Urol; 1969 Jan; 101(1):81-5. PubMed ID: 4178189
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical effects of chlormadinone acetate (CMA) on human benign prostatic hypertrophy--comparative study with hexestrol by a double blind trial (author's transl)].
    Shida K; Kondo A; Takai S; Sato S; Shimazaki J
    Horumon To Rinsho; 1979 Oct; 27(10):1159-72. PubMed ID: 92377
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of hypertrophy of the prostate with gestagens].
    Vahlensieck W; Gödde S
    Munch Med Wochenschr; 1968 Jun; 110(26):1573-7. PubMed ID: 4182927
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pathogenesis and norsteroid treatment of bladder neck adenoma (prostatic hypertrophy)].
    Magyarsóky F
    Acta Chir Acad Sci Hung; 1973 Aug; 14(3):209-22. PubMed ID: 4129777
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship between prostatic atrophy and apoptosis in the canine spontaneous benign prostatic hyperplasia (BPH) following chlormadinone acetate (CMA).
    Murakoshi M; Ikeda R; Fukui N; Nakayama T
    Tokai J Exp Clin Med; 2001 Jul; 26(2):71-5. PubMed ID: 11806444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [On medical therapy of prostate hypertrophy with a synthetic progestational hormone. (Preliminary note)].
    Frizzi V
    Minerva Med; 1970 Feb; 61(15):694-9. PubMed ID: 4190508
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of hydroxyprogesterone caproate in the treatment of benign prostatic hyperplasia.
    Jacobs D; Harper JM; Politano VA
    South Med J; 1967 Nov; 60(11):1174-6. PubMed ID: 4168673
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of anti-androgen therapy for benign prostatic hypertrophy by using transrectal prostatic ultrasonography].
    Kazama T; Mizuno I; Takamine T; Umeda K; Terada T; Ishikawa S; Fuse H; Katayama T
    Hinyokika Kiyo; 1990 Dec; 36(12):1423-7. PubMed ID: 1706136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-androgens. Animal experiments and clinical application].
    Neumann F; Steinbeck H
    Internist (Berl); 1971 May; 12(5):198-205. PubMed ID: 4103750
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.